136 related articles for article (PubMed ID: 38890744)
41. Design of a care pathway for pharmacy-based PrEP delivery in Kenya: results from a collaborative stakeholder consultation.
Ortblad KF; Mogere P; Roche S; Kamolloh K; Odoyo J; Irungu E; Mugo NR; Pintye J; Baeten JM; Bukusi E; Ngure K;
BMC Health Serv Res; 2020 Nov; 20(1):1034. PubMed ID: 33176785
[TBL] [Abstract][Full Text] [Related]
42. Acceptability and Feasibility of Pharmacy-Based Delivery of Pre-Exposure Prophylaxis in Kenya: A Qualitative Study of Client and Provider Perspectives.
Roche SD; Wairimu N; Mogere P; Kamolloh K; Odoyo J; Kwena ZA; Bukusi EA; Ngure K; Baeten JM; Ortblad KF
AIDS Behav; 2021 Dec; 25(12):3871-3882. PubMed ID: 33826022
[TBL] [Abstract][Full Text] [Related]
43. Key influences on the decision to initiate PrEP among adolescent girls and young women within routine maternal child health and family planning clinics in Western Kenya.
Rogers Z; Pintye J; Kinuthia J; O'Malley G; Abuna F; Escudero J; Mugambi M; Awuor M; Dollah A; Dettinger JC; Kohler P; John-Stewart G; Beima-Sofie K
AIDS Care; 2022 Mar; 34(3):363-370. PubMed ID: 34543077
[TBL] [Abstract][Full Text] [Related]
44. Integrating oral PrEP delivery among African women in a large HIV endpoint-driven clinical trial.
Beesham I; Welch JD; Heffron R; Pleaner M; Kidoguchi L; Palanee-Phillips T; Ahmed K; Baron D; Bukusi EA; Louw C; Mastro TD; Smit J; Batting JR; Malahleha M; Bailey VC; Beksinska M; Donnell D; Baeten JM;
J Int AIDS Soc; 2020 May; 23(5):e25491. PubMed ID: 32396700
[TBL] [Abstract][Full Text] [Related]
45. Strengthening health system's capacity for pre-exposure prophylaxis for adolescent girls and young women and adolescent boys and young men in South Africa (SHeS'Cap-PrEP): Protocol for a mixed methods study in KwaZulu-Natal, South Africa.
Nicol E; Ramraj T; Hlongwa M; Basera W; Jama N; Lombard C; McClinton-Appollis T; Govindasamy D; Pass D; Funani N; Aheron S; Paredes-Vincent A; Drummond J; Cheyip M; Dladla S; Bedford J; Mathews C
PLoS One; 2022; 17(3):e0264808. PubMed ID: 35298487
[TBL] [Abstract][Full Text] [Related]
46. The effectiveness, feasibility and acceptability of HIV service delivery at private pharmacies in sub-Saharan Africa: a scoping review.
Kuo AP; Roche SD; Mugambi ML; Pintye J; Baeten JM; Bukusi E; Ngure K; Stergachis A; Ortblad KF
J Int AIDS Soc; 2022 Oct; 25(10):e26027. PubMed ID: 36285619
[TBL] [Abstract][Full Text] [Related]
47. Evaluating the use of oral pre-exposure prophylaxis among pregnant and postpartum adolescent girls and young women in Cape Town, South Africa.
Khadka N; Gorbach PM; Nyemba DC; Mvududu R; Mashele N; Javanbakht M; Nianogo RA; Aldrovandi GM; Bekker LG; Coates TJ; Myer L; Joseph Davey DL
Front Reprod Health; 2023; 5():1224474. PubMed ID: 37795521
[TBL] [Abstract][Full Text] [Related]
48. HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.
Koss CA; Havlir DV; Ayieko J; Kwarisiima D; Kabami J; Chamie G; Atukunda M; Mwinike Y; Mwangwa F; Owaraganise A; Peng J; Olilo W; Snyman K; Awuonda B; Clark TD; Black D; Nugent J; Brown LB; Marquez C; Okochi H; Zhang K; Camlin CS; Jain V; Gandhi M; Cohen CR; Bukusi EA; Charlebois ED; Petersen ML; Kamya MR; Balzer LB
PLoS Med; 2021 Feb; 18(2):e1003492. PubMed ID: 33561143
[TBL] [Abstract][Full Text] [Related]
49. Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial.
Celum CL; Gill K; Morton JF; Stein G; Myers L; Thomas KK; McConnell M; van der Straten A; Baeten JM; Duyver M; Mendel E; Naidoo K; Dallimore J; Wiesner L; Bekker LG
J Int AIDS Soc; 2020 Nov; 23(11):e25636. PubMed ID: 33247553
[TBL] [Abstract][Full Text] [Related]
50. Oral PrEP Consultations Among Adolescent Girls and Young Women in Kisumu County, Kenya: Insights from the DREAMS Program.
Heck CJ; Mathur S; Alwang'a H; Daniel OM; Obanda R; Owiti M; Okal J
AIDS Behav; 2022 Aug; 26(8):2516-2530. PubMed ID: 35099640
[TBL] [Abstract][Full Text] [Related]
51. Getting HIV Pre-exposure Prophylaxis (PrEP) into Private Pharmacies: Global Delivery Models and Research Directions.
Roche SD; Were D; Crawford ND; Tembo A; Pintye J; Bukusi E; Ngure K; Ortblad KF
Curr HIV/AIDS Rep; 2024 Jun; 21(3):116-130. PubMed ID: 38517671
[TBL] [Abstract][Full Text] [Related]
52. PrEP uptake and early persistence among adolescent girls and young women receiving services via community and hybrid community-clinic models in Namibia.
Barnabee G; Billah I; Ndeikemona L; Silas L; Ensminger A; MacLachlan E; Korn AK; Mawire S; Fischer-Walker C; Ashipala L; Forster N; O'Malley G; Velloza J
PLoS One; 2023; 18(8):e0289353. PubMed ID: 37647257
[TBL] [Abstract][Full Text] [Related]
53. Multi-level Interventions to Promote Oral Pre-exposure Prophylaxis Use Among Adolescent Girls and Young Women: a Review of Recent Research.
Irungu E; Khoza N; Velloza J
Curr HIV/AIDS Rep; 2021 Dec; 18(6):490-499. PubMed ID: 34719745
[TBL] [Abstract][Full Text] [Related]
54. Pre-Exposure Prophylaxis (PrEP) Initiation and Retention Among Young Kenyan Women.
Ohiomoba RO; Owuor PM; Orero W; Were I; Sawo F; Ezema A; Jackson-Gibson M; Hirschhorn LR
AIDS Behav; 2022 Jul; 26(7):2376-2386. PubMed ID: 35061115
[TBL] [Abstract][Full Text] [Related]
55. Thetha Nami ngithethe nawe (Let's Talk): a stepped-wedge cluster randomised trial of social mobilisation by peer navigators into community-based sexual health and HIV care, including pre-exposure prophylaxis (PrEP), to reduce sexually transmissible HIV amongst young people in rural KwaZulu-Natal, South Africa.
Busang J; Zuma T; Herbst C; Okesola N; Chimbindi N; Dreyer J; Mtshali N; Smit T; Ngubane S; Hlongwane S; Gumede D; Jalazi A; Mdluli S; Bird K; Msane S; Danisa P; Hanekom W; Lebina L; Behuhuma N; Hendrickson C; Miot J; Seeley J; Harling G; Jarolimova J; Sherr L; Copas A; Baisley K; Shahmanesh M
BMC Public Health; 2023 Aug; 23(1):1553. PubMed ID: 37582746
[TBL] [Abstract][Full Text] [Related]
56. How a menu of adherence support strategies facilitated high adherence to HIV prevention products among adolescent girls and young women in sub-Saharan Africa: a mixed methods analysis.
Roberts ST; Mancuso N; Williams K; Nabunya HK; Mposula H; Mugocha C; Mvinjelwa P; Garcia M; Szydlo DW; Soto-Torres L; Ngure K; Hosek S
J Int AIDS Soc; 2023 Nov; 26(11):e26189. PubMed ID: 37936551
[TBL] [Abstract][Full Text] [Related]
57. Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial.
Irungu EM; Mugwanya KK; Mugo NR; Bukusi EA; Donnell D; Odoyo J; Wamoni E; Peacock S; Morton JF; Ngure K; Mugambi M; Mukui I; O'Malley G; Baeten JM;
Lancet Glob Health; 2021 Dec; 9(12):e1730-e1739. PubMed ID: 34798031
[TBL] [Abstract][Full Text] [Related]
58. Identifying Opportunities to Discuss Pre-Exposure Prophylaxis During Contraceptive Coaching Discussions With Urban Adolescent Women.
Fields NF; Wood S; Amutah C; Timko CA; Petsis D; Akers AY
J Adolesc Health; 2021 Nov; 69(5):824-830. PubMed ID: 34103237
[TBL] [Abstract][Full Text] [Related]
59. Demonstrating service delivery models for effective initiation and retention on pre-exposure prophylaxis (PrEP) among female bar workers in Dar es Salaam, Tanzania: A double randomized intervention study protocol.
Chebet JJ; Akyoo WO; Goymann H; Harling G; Barnhart DA; Mosha IH; Kamori DD; Gandhi M; Mbunda T; Kipeleka J; Sando D; Spiegelman D; Mpembeni R; Bärnighausen T
PLoS One; 2024; 19(6):e0304077. PubMed ID: 38935796
[TBL] [Abstract][Full Text] [Related]
60. A Text Messaging-Based Support Intervention to Enhance Pre-exposure Prophylaxis for HIV Prevention Adherence During Pregnancy and Breastfeeding: Protocol for a Randomized Controlled Trial.
Mogaka JN; Otieno FA; Akim E; Beima-Sofie K; Dettinger J; Gomez L; Marwa M; Odhiambo B; Ngure K; Ronen K; Sharma M; John-Stewart G; Richardson B; Stern J; Unger J; Udren J; Watoyi S; Pintye J; Kinuthia J
JMIR Res Protoc; 2023 Jan; 12():e41170. PubMed ID: 36716092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
